Washington, United States,
08048034981

OBESITY/WEIGHT MANAGEMENT · Semaglutide (1.34mg/ml)

Sematrinity 1 mg injection

In stock

Description

Semaglutide injection products, primarily branded as Ozempic and Wegovy, are GLP-1 receptor agonists designed for weekly, subcutaneous, self-administered weight management and type 2 diabetes treatment. These products are typically indicated for chronic weight management alongside lifestyle changes, or glycemic control in adults.

Specifications

Strength 1 mg
UsageOnce-weekly injection
FormPre-filled Pen (PFS/PFP)
AdministrationSubcutaneous injection
Main Ingredients Semaglutide (1.34mg/ml) Semaglutide